
GC75801
GSK_WRN4
Also known as 6-cyclohexyl-N-[(3R)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-2-oxo-1H-pyridine-3-carboxamide
GSK_WRN4 is a WRN helicase inhibitor (pIC50=7·6) with anticancer activity
ChemicalCAS2923008-66-4MW336.41FormulaC16H20N2O4S
- CAS number
- 2923008-66-4
- Molecular weight
- 336.41
- Formula
- C16H20N2O4S
- Solubility
- DMSO: 100 mg/mL (297·26 mM; Need ultrasonic)
- InChIKey
- UUGZQYZJHNKGTI-GFCCVEGCSA-N
- Catalogue number
- GC75801
- Brand
- GLPBIO
Computed properties PubChem CID 172636055 · XLogP 1.3 · TPSA 101 Ų · H-bond donors 2
- XLogP
- 1.3
- TPSA
- 101 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 23
SMILES C1CCC(CC1)C2=CC=C(C(=O)N2)C(=O)N[C@H]3CS(=O)(=O)C=C3
Computed descriptors from PubChem (CID 172636055), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il